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Abstract
Caffeine is a widely utilized performance-enhancing supplement used by athletes and non-athletes alike. In recent years, a 
number of meta-analyses have demonstrated that caffeine’s ergogenic effects on exercise performance are well-established 
and well-replicated, appearing consistent across a broad range of exercise modalities. As such, it is clear that caffeine is an 
ergogenic aid—but can we further explore the context of this ergogenic aid in order to better inform practice? We propose 
that future research should aim to better understand the nuances of caffeine use within sport and exercise. Here, we propose a 
number of areas for exploration within future caffeine research. These include an understanding of the effects of training status, 
habitual caffeine use, time of day, age, and sex on caffeine ergogenicity, as well as further insight into the modifying effects 
of genotype. We also propose that a better understanding of the wider, non-direct effects of caffeine on exercise, such as how 
it modifies sleep, anxiety, and post-exercise recovery, will ensure athletes can maximize the performance benefits of caffeine 
supplementation during both training and competition. Whilst not exhaustive, we hope that the questions provided within this 
manuscript will prompt researchers to explore areas with the potential to have a large impact on caffeine use in the future.
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Key Points 
Caffeine is a well-replicated performance-enhancing 
supplement, with these effects established at meta-
analysis level; as such, further research exploring the 
straightforward ergogenic effects of caffeine is unlikely 
to alter practice.
However, there are many unanswered questions with 
regard to the use of caffeine in sport which represent 
promising avenues to enhance our understanding and 
provide some nuance into the use of caffeine around 
exercise.
These unanswered questions include whether the 
ergogenic effects of caffeine alter with sex, time of day, 
genotype, habitual use, and training status, and there is a 
need for a greater understanding of the effects of caffeine 
on performance anxiety and post-exercise recovery.
1 Introduction
Caffeine (1,3,7-trimethylxanthine) is a popular ergogenic 
aid, widely used by athletes at all levels [1, 2]. The perfor-
mance-enhancing effects of caffeine have been studied for 
over 100 years, with the first known study on the subject 
published in 1907 [3]. Since these early studies, interest 
in caffeine has developed, to the point that it is now one 
of the most well-established ergogenic aids, with perfor-
mance-enhancing effects across a wide range of exercise 
modalities [4].
Several meta-analyses examining the effects of caf-
feine ingestion on exercise performance have been con-
ducted, exploring the effects of caffeine on a broad array 
of exercise tests, including 1 repetition maximum (1 RM) 
strength [5, 6], isokinetic peak torque [7], vertical jump 
height [6], power output across different exercise types 
[8–10], aerobic endurance performance [8, 11–15], and 
muscular endurance [5, 16]. The statistically significant 
effect sizes from these individual meta-analyses ranged 
from 0.16 (for isokinetic peak torque [7]) to 0.51 (for 
aerobic exercise performance [13]), suggesting that caf-
feine can reliably enhance performance. Further sys-
tematic reviews have highlighted an ergogenic effect of 
caffeine on sport-specific endurance [17], power-based 
sports [18], and resistance exercise [19, 20]. Two meta-
analyses [21, 22] have reported no effect of caffeine on 
sprint and repeated sprint performance, although a number 
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of individual studies utilizing either caffeine-containing 
energy drinks [23] or caffeine alone [24–27] have demon-
strated a potentially ergogenic effect of caffeine on both, 
suggesting a need for further research in this area.
Alongside its well-established effects on a variety of 
physical performance tasks, caffeine also exerts acute cog-
nitive benefits upon ingestion, especially in sleep-deprived 
subjects. This has been explored in military personnel, 
with caffeine demonstrated to improve cognitive aspects 
such as vigilance, memory, and mood, along with physical 
performance, both during overnight operations and follow-
ing sleep restriction [28–30], results which have been rep-
licated in the general public (for review, see Ruxton [31]). 
Similar findings have been reported in athletes. For exam-
ple, Cook and colleagues [32] reported that caffeine doses 
of 1 and 5 mg/kg ameliorated loss of skill performance in 
elite rugby players following sleep restriction. In non-sleep 
restricted subjects, caffeine may enhance sports-specific 
skill performance (for review, see Baker et al. [33]). Fur-
thermore, athletes are prone to mental fatigue, which can 
impair physical [34, 35] and sport-specific skill-based 
performance [36] and cognitive ability [37]. In mentally 
fatigued individuals, caffeine has been shown to enhance 
endurance performance [38] along with skill performance 
and cognitive function in sport-specific situations [39, 40], 
although this latter finding is equivocal [41, 42].
Given caffeine’s popularity, both in its use by athletes 
and its interest to researchers, it is tempting to believe that 
we potentially know all there is to understand about the use 
of caffeine in sport. The purpose of this review is to explore 
some areas where our knowledge of caffeine’s performance 
benefits is not clear, prompting potential directions for 
researchers to explore in the future.
2  What Else Do We Need to Know About 
Caffeine in Sport?
At present, the performance-enhancing effects of caffeine on 
a plethora of exercise modes are well-established at meta-
analysis level [5–16]. As such, it is clear that caffeine is an 
effective ergogenic aid—but can we better understand the 
context around its use to better inform practice? We propose 
that future research should instead attempt to explore the 
nuances of caffeine use. Given the high prevalence of caf-
feine ingestion amongst athletes [1, 2], such an approach is 
likely to yield additional performance enhancement. General 
caffeine guidelines recommend the consumption of 3–6 mg/
kg of caffeine, typically 60 min before the start of exercise 
[43]; however, recently it has become apparent that there is 
considerable inter-individual variation in response to such 
a standardized protocol, with a variety of factors potentially 
driving this variation [44]. A greater understanding of these 
factors, explored in the following sections, will, hopefully, 
allow for the enhanced personalization of caffeine usage 
guidelines in the future.
2.1  What are the Wider, Non‑direct Influences 
of Caffeine on Performance?
Historically, the interest in caffeine within sports science has 
been on its performance-enhancing effects. However, it is 
important to understand the wider contexts of caffeine use, 
and the potential impact these could have on performance. 
For example, caffeine has been shown to potentially elevate 
feelings of anxiety [45], which is an important consideration 
for athletes—does pre-competition caffeine consumption 
increase anxiety to the extent that it becomes performance 
limiting? An individualized approach may be required here; 
some individuals may need an increase in arousal prior to 
some competitions, and caffeine may be an effective way to 
achieve this [46]. Conversely, for major competitions where 
anxiety and arousal are likely to be increased, pre-competi-
tion caffeine may need to be reduced, or avoided altogether, 
in order to protect performance [44].
Caffeine ingestion can also impact the subsequent abil-
ity to both fall asleep and achieve high-quality sleep [47, 
48]. This effect is potentially prolonged, with Drake and 
colleagues [47] reporting that 400 mg of caffeine, ingested 
6 h prior to bedtime, disrupted sleep quality, reduced sleep 
duration, and increased sleep latency. This is of inter-
est within sporting contexts, where competitions often 
occur in the evening; here, pre-competition caffeine use 
may have a carryover effect, reducing sleep quality and 
duration, and subsequently harming recovery. This was 
explored by Dunican and colleagues [48] in a Super Rugby 
team. Here, players consumed caffeine prior to an even-
ing match; post-match salivary concentrations of caffeine 
were associated with an increase in sleep latency and a 
decrease in both sleep duration and efficiency that evening 
compared to baseline data. Further research is required 
to understand what effect, if any, caffeine-induced sleep 
loss may have on subsequent performance (for example, 
across a 2-day competition), as well as replicating these 
initial findings. Enhancing our understanding in this area 
will undoubtedly assist in the provision of individualized 
caffeine guidelines around competition, with a pragmatic 
approach most likely required; is the decrease in sleep 
quality following caffeine ingestion a worthwhile price to 
pay for enhanced performance?
Aside from affecting sleep, caffeine may also mod-
ify post-training and competition recovery. In a recent 
review, Loureiro and colleagues [49] reported conflicting 
data regarding the effects of caffeine on muscle glycogen 
recovery, suggesting a need for further research in this 
area. Interestingly, cafestol and caffeic acid—ingredients 
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of coffee—appear to enhance muscle glycogen recovery 
[49], suggesting that the use of coffee as a means to receive 
caffeine pre-exercise may confer some additional benefits 
compared to other caffeinated mediums. In another review 
[20], the authors concluded that caffeine ingestion prior to 
resistance training may reduce the occurrence of delayed 
onset of muscle soreness, recommending further research 
to explore this. Similar results have been reported following 
endurance exercise [50]. However, caffeine appears to delay 
autonomic recovery following exercise [51, 52]. As such, 
future research should seek to better understand the effect 
of pre-exercise caffeine ingestion on post-exercise recov-
ery, particularly given that pre-exercise caffeine intake may 
increase physical exertion and hence muscle damage and 
training load. Furthermore, a better understanding of the 
role of caffeine on muscle glycogen recovery may lead to the 
use of caffeine post-exercise as a method to enhance recov-
ery, although the demonstrated negative effect on autonomic 
function would require consideration.
Furthermore, genetic variation (see Sect. 2.2) is likely 
to contribute to the effect of caffeine on these aspects, with 
single-nucleotide polymorphisms (SNPs) in ADORA2A and 
DRD2 associated with caffeine-induced anxiety and sleep 
disturbances [53, 54], demonstrating an interaction between 
some of these remaining questions regarding the use of caf-
feine within sport.
2.2  What are the Effects of Genotype on Caffeine 
Ergogenicity?
Three recent reviews have explored the potential impact 
of genetic variation on the ergogenic effects of caffeine 
on performance [44, 54, 55], with two SNPs in CYP1A2 
and ADORA2A emerging as potential candidates. Of these, 
CYP1A2 is most well-explored, with at least nine studies 
examining its effect on caffeine ergogenicity [56–64]; for 
a detailed summary of these studies, readers are directed 
to Fulton et al. [54]. The majority of these studies utilized 
small sample sizes, potentially hampering their statistical 
power and the derivation of firm conclusions. This notion is 
mirrored within the results, with some studies reporting no 
effect of the polymorphism [52, 56, 57, 59, 61] and others 
a modifying effect, but in different directions [58, 60, 63, 
64]. In the study with the largest cohort (n = 101), Guest 
and colleagues [58] reported that moderate (4 mg/kg) doses 
of caffeine were ergogenic for AA genotypes, ineffective 
for AC genotypes, and ergolytic for CC genotypes. CYP1A2 
encodes for cytochrome P450 1A2, the enzyme responsi-
ble for ~ 95% of all caffeine metabolism [65]. Subjects with 
the AA genotype tend to produce more of this enzyme, and 
hence metabolize caffeine quicker than AC and CC geno-
types [66]. A potential proposed mechanism for the impact 
of CYP1A2 on caffeine ergogenicity is that the downstream 
metabolites of caffeine (paraxanthine, theobromine, and the-
ophylline) have additional ergogenic effects, which is why 
the fast-metabolizing AA genotypes experience a further 
advantage [63]. Additionally, as caffeine is a vasoconstrictor, 
CC genotypes might experience prolonged vasoconstriction, 
harming endurance performance [58]. If these mechanisms 
are correct—and further work should aim to elucidate this—
then there is the potential that ingestion of caffeine a greater 
period of time prior to exercise could improve caffeine’s 
ergogenic effects in C allele carriers [67].
As research in this field evolves, we should be able to 
gain a broader understanding as to the genetic influence on 
the effects of caffeine, be that specifically from a perfor-
mance standpoint [46] or wider aspects influencing perfor-
mance, such as anxiety [68, 69], sleep disturbances [70], and 
habitual use [71]. There is the potential that SNPs within 
genes located within the dopaminergic (such as DRD2 and 
COMT [69, 72]), adenosine (AMPD1 [73]), and adrenergic 
(ADRA1A, ADRA2B, ADRB1, ADRB2, and ADRB3 [73]) 
systems may contribute to the demonstrated inter-individual 
variation in response to an acute caffeine dose within sport-
ing contexts. This aspect also has important implications for 
caffeine research; if genotype does modify caffeine’s ergo-
genic effects between individuals, then these individual dif-
ferences, when averaged across groups, may be masked, pro-
viding misleading results. However, the addition of genetic 
information to caffeine-based research may be practically 
problematic, as it is costly, and we do not fully understand 
which genetic variants modify caffeine’s ergogenic effects, 
meaning any potential stratification based on genotype may 
be incomplete.
2.3  Does Time of Day Impact the Ergogenic Effects 
of Caffeine?
There is a potential effect of circadian rhythm on perfor-
mance, with some studies demonstrating that performance 
in a given task is better in the afternoon compared to the 
early morning [74–76]. Specifically, muscular abilities, 
such as strength, appear to peak in the evening hours [77]. 
For example, Guette et al. [78] reported significantly lower 
maximal torque production at 06:00 and 10:00 h (~ 90% 
of maximum values) compared to strength performance at 
18:00 h (~ 99% of maximal values). As athletes often have 
to undertake training sessions, or even compete, early in the 
morning, there is an increased interest in strategies to off-set 
this morning performance decrement.
Given its stimulatory role, caffeine represents a potential 
method of mitigating the performance decrement seen in 
the morning hours [79], particularly as studies have dem-
onstrated that caffeine can serve to preserve performance 
during periods of sleep deprivation [32, 80]. This hypothesis 
has been tested by a number of recent studies [79, 81–85], 
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detailed in Table 1. Mora-Rodríguez and colleagues [81] 
demonstrated that morning caffeine ingestion increased per-
formance to that of an evening resistance exercise session. 
In a later study, the same research group observed that caf-
feine enhanced performance in the morning but not in the 
evening hours [82], with similar results observed by Souissi 
et al. [84]. Interestingly, Mora-Rodríguez and colleagues 
[82] reported a higher incidence of side effects upon p.m. 
caffeine ingestion.
In another study [83], caffeine appeared to exert a greater 
ergogenic effect (+ 2.3%) on 3-km cycling time trial per-
formance when consumed in the morning compared to the 
evening (+ 1.4%). Again, cycling performance is generally 
impaired in the morning versus evening hours [86], and 
these differences may explain the possible greater effects 
of caffeine ingestion in the morning. Caution must be exer-
cised when interpreting these results, however, as the authors 
utilized the magnitude-based inference method which has 
recently received criticism due to inflated type I error rates 
[87]. Finally, two studies [79, 85] have reported no effect on 
time of day on caffeine ergogenicity.
The morning-evening differential in performance, and the 
potential modifying effect of caffeine ingestion, is an impor-
tant methodological consideration for researchers to keep in 
mind, and report in future studies. A recent meta-analysis [7] 
reported an ergogenic effect of caffeine on isokinetic peak 
force (pooled effect size 0.16). Closer scrutiny of the meth-
ods used in the included studies indicates that only a single 
study [88] detailed the time of day at which the exercise test-
ing was performed, which for both the caffeine and placebo 
trials was between 09:00 and 12:00 h. Of the ten included 
studies within that meta-analysis, this study reported the 
largest effect size (0.53) of caffeine on isokinetic strength, 
potentially suggesting that the time of day of caffeine inges-
tion represents an important variable influencing the mag-
nitude of caffeine’s ergogenic effects.
Given the relatively sparse research around this question, 
future work should aim to better understand what role—if 
any—time of day has on the effects of caffeine. This infor-
mation could further be utilized to enhance caffeine strat-
egies for athletes, especially given the potential effects of 
caffeine on sleep disturbances (Sect. 2.1). This could also 
be important from the standpoint of travel across time 
zones, an increasingly frequent occurrence for high level 
athletes, and the associated jet lag, which has been shown 
to harm performance [89, 90]. Caffeine has been demon-
strated to mitigate the negative effects of jet lag on perfor-
mance [91] and daytime sleepiness [92], and may assist in 
the retraining of circadian rhythm following a large time 
change [89–94], although it remains understudied in this 
regard [95, 96]. Future studies carried out within the area of 
caffeine and circadian rhythms should consider exploring 
the impact of caffeine on jet lag management and time-shift 
in athletes. Furthermore, it would likely be worthwhile to 
assess whether an individual’s chronotype further modifies 
caffeine’s ergogenic effects across different times of day. 
Finally, researchers should report the timing of performance 
tests utilized within caffeine trials, in order to control for this 
potentially modifying variable.
2.4  Does Caffeine Ergogenicity Vary According 
to Training Status?
It has been long perpetuated in the scientific literature 
that the effects of caffeine on exercise performance differ 
between trained and untrained individuals, popularized by 
the work by Collomp et al. [24]. Here, seven trained and 
seven recreational swimmers had their swimming perfor-
mance tested on two occasions (following the ingestion of 
placebo and caffeine), with the results revealing that only the 
trained swimmers experienced improvements in swimming 
velocity following caffeine ingestion. Similar findings were 
observed by Astorino et al. [97], who reported that trained 
individuals experienced improvements in cycling time-trial 
performance following caffeine ingestion, while those clas-
sified as ‘active’ did not.
Burke [98] argued that trained, as opposed to untrained, 
individuals might have higher reliability of exercise perfor-
mance, and, therefore, less day-to-day performance varia-
tion. Reliability of performance may be of importance in this 
line of research, as tests with low reliability may increase 
the risk of type II errors and are, therefore, not suitable 
when examining small changes in performance [99]. Hypo-
thetically, in untrained individuals, day-to-day performance 
variation is greater, potentially preventing the detection of 
small performance increases following caffeine ingestion. 
While such ideas are based on a solid rationale [98], stud-
ies examining the test–retest reliability of performance 
tests such as the Yo–Yo test [100], 400-m running [101], 
power output on the rowing ergometer [102], and 1 RM test 
[103] in trained and untrained individuals report that both 
populations exhibit comparable test–retest reliability. These 
results indicate that other factors are likely responsible for 
the divergent responses to caffeine ingestion between trained 
and untrained individuals.
Physiologically, it remains unclear why trained individu-
als might experience greater performance improvements 
than untrained subjects following caffeine ingestion. Com-
paring trained cyclists/triathletes to ‘active’ individuals, 
Skinner et al. [104] reported that time to peak and peak 
caffeine concentrations were similar in both groups. There-
fore, the availability of caffeine within the blood might not 
explain the performance differences following caffeine 
ingestion in trained and untrained individuals noted by Col-
lomp et al. [24] and Astorino et al. [97].
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The ergogenic effects of caffeine on exercise performance 
predominantly appear related to caffeine’s binding to adeno-
sine receptors [105]. Mizuno et al. [106] reported that trained 
men have greater adenosine  A2a receptor densities than 
untrained subjects; it might be that this increase in adenosine 
receptor density in trained individuals allows greater binding 
of caffeine to these receptors, increasing the magnitude of 
the acute improvements in exercise performance following 
caffeine ingestion. This idea, however, remains speculative; 
in contrast to the work by Collomp et al. [24] and Astorino 
et al. [97], other studies report that caffeine ingestion may 
produce similar performance benefits in both trained and 
untrained (or recreationally trained) individuals [107, 109]. 
Moreover, in some cases, caffeine ingestion enhanced per-
formance in untrained but not in trained individuals [109]; 
see Table 2 for a summary of these studies.
However, we can potentially gain some insights from ani-
mal studies utilizing isolated skeletal muscle, which provide 
a potentially useful model for the exploration of caffeine’s 
ergogenic effects as animals tend not to be habitual users 
of caffeine, and, by bathing the muscle in a caffeine solu-
tion, differences in caffeine digestion and pharmacokinetics 
are largely overcome [110]. A recent study utilizing such 
a model [111], in which mice either underwent an 8-week 
exercise intervention or acted as an untrained control, sug-
gested that 70 μM of caffeine (representative of a maximal 
physiological dose [4]) enhanced muscle power to the same 
extent in the trained and untrained isolated mice muscle. 
This suggests that training status does not modify caffeine’s 
ergogenic effects, at least in terms of direct muscle function. 
Further work in human subjects, including those with longer 
(i.e., multiple years) training histories, are required to further 
explore this hypothesis.
From a different perspective, it could be argued that in 
highly trained individuals (i.e., elite athletes), there is less 
‘potential for improvement’ following caffeine ingestion, 
as these individuals are, by definition, towards the upper 
end of human exercise performance capabilities and are 
approaching absolute physical limits [112, 113]. Given the 
already high performance capabilities of these individuals, 
it remains unclear if they can be further enhanced follow-
ing caffeine ingestion. These aspects remain under-explored 
given the lack of studies conducted on elite athletes. Due 
to the limited access to elite athletes and the finite nature 
of these individuals, even further case studies on this topic 
would help to expand our current understanding of this topic 
[114].
In summary, the current evidence on the effects of caf-
feine among trained and untrained individuals is based on a 
handful of human studies which reported conflicting find-
ings. This lack of studies opens up an avenue for researchers 
to conduct future high-quality studies on the topic as this is 
an area that merits further work.
2.5  Does Caffeine Ergogenicity Vary According 
to Sex?
A major limitation of the present body of research on caf-
feine’s ergogenic effects is that the majority of studies utilize 
male subjects [20, 43]. As an illustration, a recent meta-
analysis included nine studies, consisting of 88 pooled par-
ticipants, of which only three were female [14]. A likely 
explanation for this difference between sexes is that females 
represent a slightly more complex cohort to conduct caffeine 
research on, as the use of oral contraceptives [115] and dif-
ferences in menstrual cycle stage [116] can alter caffeine 
metabolization speeds, which in turn may alter the ergogenic 
effects of caffeine. However, a number of studies demon-
strate that caffeine has an ergogenic effect in females, both in 
terms of resistance [117, 118] and endurance exercise [119, 
120]. As such, caffeine is clearly ergogenic for females, but 
questions remain as to whether there are differences in opti-
mal caffeine strategies between the sexes, especially given 
the differences in caffeine metabolization speed between 
males and females.
Several studies compare the effects of caffeine amongst 
males and females, reporting similar effects in both sexes 
[121–123], outlined in Table 3. Whilst other studies have 
recruited both sexes, they generally analyzed males and 
females together [107, 124]. However, in order to expand 
our understanding of potential sex differences in response to 
caffeine ingestion, further work should aim to recruit males 
and females, and undertake between-group comparisons of 
the sexes. A similar approach was utilized by Skinner et al. 
[120], who reported that the magnitude of ergogenic effects 
following ingestion of 3 mg/kg caffeine 90-min prior to a 
cycle test was the same (~ 4%) between the sexes. However, 
there were significant differences in caffeine concentrations 
post-exercise, with females having a greater amount. This 
suggests that females do not metabolize caffeine as rapidly 
as males, hinting that, similar to CYP1A2 CC genotypes, 
females might benefit from a longer time between caffeine 
ingestion and exercise trials [67]; such a hypothesis requires 
testing.
2.6  Does Habitual Caffeine Use Alter Its Ergogenic 
Effects?
Whilst habituation is commonly identified as a factor 
modifying the acute response to caffeine supplementation 
[125], research on this topic demonstrates conflicting find-
ings [126]. A recent review [126] explored the influence of 
habitual caffeine use on the ergogenic effects of an acute 
caffeine dose. This subject is surprisingly under-studied 
in human subjects, with the authors finding only four 
studies [127–130] utilizing a performance task. Of these, 
two reported a blunting (but not elimination) of caffeine’s 
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acute ergogenic effects with habitual use [128, 129], and 
two reported no differences in response to acute caffeine 
ingestion between individuals with different habitual caf-
feine intakes [127, 130]. These mixed results drove the 
authors to propose that the difference between habitual 
and pre-exercise caffeine dose is potentially important; 
specifically, they hypothesized that high habitual caffeine 
users perhaps require a pre-exercise caffeine dose in excess 
of their habitual intake [126]. Further research is required 
to better understand whether this is indeed the case, espe-
cially in light of the recent findings by Lara et al. [131]. 
Here, participants undertook a double-blind, placebo-con-
trolled, randomized cross-over study, with subjects par-
ticipating in two 20-day protocols, one with daily caffeine 
intake amounting to 3 mg/kg, the other with the consump-
tion of placebo capsules. At regular intervals, the subjects 
undertook a maximally graded time-to-exhaustion cycle 
ergometer test, along with a 15-s maximal cycle ergometer 
sprint, with the exercise bout commencing 60 min follow-
ing capsule ingestion. The authors found that, whilst caf-
feine remained ergogenic throughout the 20-day period, its 
ergogenic effects were attenuated. Such a finding suggests 
that partial habituation may occur. Conversely, Sabol et al. 
[132] reported that habitual caffeine use had no effect on 
the ergogenic effects of caffeine in medicine ball throw 
and vertical jump tests, with these latest conflicting studies 
further highlighting the need for additional studies in this 
area. Relevant studies in this area are outlined in Table 4.
Alongside the issue of caffeine habituation is the issue 
of caffeine withdrawal as a potential method to enhance 
caffeine’s ergogenic effects. This becomes an issue if 
habitual caffeine use does reduce the performance benefits 
associated with its ingestion, which, as discussed above, 
is currently unclear. In a recent review [126], the authors 
identified three studies directly examining the effects of 
caffeine withdrawal on exercise performance [133–135], 
with the finding that a pre-exercise caffeine withdrawal 
period had no impact on caffeine’s ergogenic effects; this, 
along with the potential downside of caffeine withdrawal, 
led the authors to conclude that such a withdrawal period 
was unnecessary.
Furthermore, several methodological aspects need to be 
highlighted for future studies in this area. One such aspect 
is the reliability of the exercise test. For example, Bell and 
McLellan [128] explored the effects of caffeine ingestion 
between caffeine users and non-users utilizing a time-to-
exhaustion test. This may be relevant, given that these tests 
have been found to have lower reliability than time-trial 
tests [101]. Therefore, employing a test with a high meas-
urement error can confound study results, possibly leading 
to erroneous inferences regarding the effects of caffeine 
among low and high habitual caffeine users. Similarly, the 
authors of this study (and other studies; e.g., Dodd et al. 
[127]) did not report if the questionnaire used for assessing 
habitual caffeine intake was previously validated. Therefore, 
future studies should ensure that a validated questionnaire 
for assessing habitual caffeine intake is used. An additional 
issue in previous studies investigating this topic is that they 
classify the participants on a broad binary spectrum as 
caffeine ‘users’ and ‘non-users.’ For example, Dodd et al. 
[127] classified non-users as those ingesting 25 mg of caf-
feine per day, while high users were classified as those that 
ingesting > 300 mg/day; therefore, individuals in the mid-
dle range of daily caffeine intake are disregarded. This may 
be problematic because the middle range likely represents 
the majority of the population ingesting caffeine; for exam-
ple, the average consumption of caffeine among the healthy 
population in the USA is 165 mg/day [136]. To increase 
their generalizability, future studies should consider using a 
more comprehensive range of classifying habitual caffeine 
Table 3  Summary of some studies exploring the effects of caffeine between men and women
1 RM 1 repetition maximum
Reference Sample Caffeine dose Performance metric Main findings
Butts and Crowell [121] 13 young men and 15 women 300 mg Cycling time to exhaustion Caffeine ingestion did not improve 
time to exhaustion in both sexes
Sabblah et al. [122] 10 young men and 8 women 5 mg/kg Weight lifted in the squat and 
bench press 1 RM; repetitions to 
muscle failure with 40% 1 RM 
in the bench press
Caffeine ingestion enhanced weight 
lifted in the 1 RM bench press 
in men and women; no effects of 
caffeine were observed for 1 RM 
squat and 40% 1 RM in the bench 
press performance to muscle 
failure in both sexes
Skinner et al. [120] 16 young men and 11 women 3 mg/kg Cycling time to exhaustion Caffeine ingestion improved time 
to exhaustion both in men and 
women
Suvi et al. [123] 13 young men and 10 women 6 mg/kg Walks until volitional exhaustion Caffeine ingestion did not improve 
time to exhaustion in both sexes
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users, as recently demonstrated by Gonçalves et al. [130]. 
Finally, given the wide variation in caffeine concentrations 
both between caffeine sources and within the same caffeine 
source at different time points [137, 138], the accurate quan-
tification of habitual caffeine use is problematic [139]. A 
potential solution is the measurement of objective markers, 
such as urinary caffeine output or plasma caffeine/caffeine 
metabolite levels [140, 141], although such an approach 
increases the methodological challenges.
2.7  How Should Caffeine be Utilized Within 
Repeated Competitive Bouts?
Athletes are often required to undertake numerous competi-
tive bouts within a short time frame; for example, at the 2017 
World Athlete Championships, the semi-finals and finals of 
the 100 m were separated by less than 3 h. Whilst research 
has established that caffeine is ergogenic, its use around 
repeated competitive bouts is poorly understood [142]. 
There are a number of issues requiring consideration here; 
if the second competitive bout is within the period of time in 
which plasma caffeine concentrations are maintained, what 
effect, if any, does a second caffeine dose have? Similarly, 
because caffeine can increase work rate [143], is it likely to 
increase fatigue or muscle damage from the initial competi-
tive bout that will carry over to the subsequent bout—and, 
if so, does this affect performance [144]? How might this 
affect subsequent sleep (Sect. 2.1)? To what extent does 
inter-individual variation modify these factors (Sect. 2.2)? 
It is important that future research replicates how athletes 
utilize caffeine in the real world, in order to help develop 
answers to these questions.
There are some initial attempts to answer these questions. 
For instance, Bell and McLellan [145] reported that inges-
tion of 5 mg/kg of caffeine prior to morning exercise acutely 
enhanced performance, and this ergogenic effect was main-
tained in a second exercise bout performed 6 h later. The 
maintenance of the ergogenic effect is likely explained by 
caffeine’s half-life, which is generally 4–6 h [4]. In the same 
study, re-dosing with an additional 2.5 mg/kg of caffeine did 
not further improve afternoon performance, suggesting that 
re-dosing with caffeine prior to the second exercise bout 
is potentially unnecessary. In contrast, Negaresh and col-
leagues [146] explored the impact of single (10 mg/kg or 
4 mg/kg) or repeated (5 × 2 mg/kg) caffeine doses on wres-
tling performance, investigated using five performance tests 
separated by 45–180 min. The repeated dosing approach 
enhanced performance relative to placebo in the initial four 
exercise tests, whilst the 10 mg/kg dose only enhanced the 
first bout, and 4 mg/kg had no ergogenic effect. Given the 
limited number of studies conducted thus far, further explo-
ration in this area is required.
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2.8  Does Caffeine Modify Training Adaptations?
Caffeine has a clear acute ergogenic effect on exercise per-
formance. Given that the effects of caffeine are repeatable 
across days [147], ultimately, practitioners are also interested 
in determining whether the use of caffeine, if continued over 
time, also impacts long-term training adaptations. The sci-
entific attempts to answer this question are unfortunately 
almost non-existent. One study worth discussing is that of 
Malek et al. [148]; here, 36 participants were randomized 
to receive either a placebo (n = 18) or a caffeine-containing 
supplement (three pills equating a total of 201 mg of caf-
feine; n = 18) each day (on training days, 60-min pre-exer-
cise). The training sessions consisted of treadmill running 
for 45 min and were conducted three times per week, for 
8 weeks. Pre- to post-intervention, both groups experienced 
improvements in peak oxygen consumption (VO2peak), with 
no significant between-group differences. These initial 
results suggest that chronic caffeine use might not augment 
adaptations to long-term training. However, while interest-
ing, this study also had several limitations. For example, 
there was no acute component, and therefore, it remains 
unclear if this supplement was even effective for acute 
improvements in performance. Secondly, the participants 
ingested a supplement that contained caffeine, but also over 
ten other ingredients. Therefore, any potential effect of caf-
feine could not be isolated.
Future studies are needed to explore this area as there is 
a logical basis for which caffeine might augment adapta-
tions to training. In resistance exercise, for example, caf-
feine can acutely increase total volume load [5]. If continued 
over time, the cumulative effect of these acute performance 
increases might also impact hallmark resistance-train-
ing adaptations, such as skeletal muscle hypertrophy and 
increased strength, both of which appear to be augmented 
with increased volume [149, 150]. Furthermore, as caffeine 
ingestion pre-exercise may delay exercise-induced fatigue, 
individuals may be able to train for more extended periods 
with a higher exercise quality, which, subsequently, may 
enhance long-term training adaptations. Until future long-
term studies are conducted, these ideas remain speculative, 
and future work is evidently needed.
2.9  How Should Caffeine be Consumed?
In the majority of caffeine-based research studies, caffeine 
is consumed in its anhydrous, powdered form. However, 
in practice, athletes consume caffeine via a broad array of 
mediums, including coffee [151], energy drinks [22], bars 
and gels [152], nasal sprays [153], and chewing gum [154]. 
In some cases, the caffeine itself is not ingested, but rinsed 
round the mouth [155], with the proposed mechanism that 
the caffeine molecules bind to adenosine receptors found 
there [156].
A summary of the research into many of these alterna-
tive methods of caffeine administration was provided in an 
excellent recent review by Wickham and Spriet [157], to 
which interested readers are directed. For many of the alter-
native caffeine administration methods, there is surprisingly 
scarce research; for example, only two studies have explored 
the use of caffeinated gels on sporting performance [157]. 
Whilst early research suggests such alternative methods may 
be useful, further work is required to determine their effi-
cacy [157], and we should seek to understand the situations 
in which each provide the optimal benefit. As an example, 
when administered in the form of caffeinated chewing gum, 
caffeine appears to be absorbed more rapidly [158], suggest-
ing that it could be of greater use when a quicker effect is 
required—for example, during the 15-min half-time period 
in soccer. Similarly, a caffeine mouth-rinse represents a 
potentially effective method of providing a final pre-com-
petition/exercise trial caffeine dose, as research has shown 
ergogenic effects immediately following such a mouth rinse 
[157]. The use of caffeinated gels may be advantageous as 
caffeine has been shown to enhance glucose absorption, sug-
gesting that, when combined with the carbohydrate found 
in caffeinated gels, it may enhance performance to a greater 
extent than a carbohydrate gel alone [159]. Finally, non-
ingestion methods of caffeine administration may also be 
useful for athletes suffering from gastrointestinal distress 
around exercise, particularly when considering that caffeine 
can act as a gastric irritant [160]. Enhancing our knowl-
edge in this area, particularly with regard to the determina-
tion of an optimal caffeine dose for each method, whether 
a dose–response relationship exists, if there are any advan-
tages to repeated intakes during an exercise bout, and the 
optimal timing of each method, therefore holds wide future 
promise.
An additional way in which caffeine is ingested is via cof-
fee [161]. Whilst coffee, as a method of caffeine ingestion, 
has been shown to be ergogenic [162], although not une-
quivocally [163], the question remains as to whether it is as 
effective as caffeine in isolation at improving performance. 
Graham [4] concluded that coffee was “probably inferior to 
caffeine as an ergogenic aid,” and that some of its multiple 
compounds may reduce the ergogenic effects of caffeine. 
Hodgson et al. [151] reported that both caffeine and coffee, 
standardized to deliver a caffeine dose of 5 mg/kg, were sim-
ilarly efficacious in enhancing performance above placebo 
in a cycle ergometer test. Two studies [164, 165] compared 
the use of coffee and caffeine anhydrous for their ergogenic 
effects on strength and sprint performance, reporting similar 
ergogenic effects for both modalities. These results suggest a 
similar ergogenic effect of both caffeine and coffee, provided 
the caffeine dose is matched.
 C. Pickering, J. Grgic 
Practically, the use of coffee as the main caffeine source 
by athletes prior to competition may be problematic. Caf-
feine concentrations vary between coffee blends and brands 
and in the same coffee source over time [137, 138, 166], 
although such a problem is not unique to coffee [167]. Addi-
tionally, coffee tends to be consumed whilst warm, which 
may cause issues with thermoregulatory control, especially 
in warm climates [168], and represents a potential logistical 
issue, as it needs to be transported to the venue in a container 
that maintains its temperature. However, for non-athletes 
looking for a pre-exercise caffeine boost, or for athletes in 
a more relaxed training environment, there appears to be 
little downside to the use of coffee as a pre-exercise perfor-
mance-enhancer. Given the ubiquity of coffee consumption 
in modern society, further research into the ergogenic effects 
of coffee, when compared to caffeine alone, is warranted, 
including that of potential side effects such as gastrointesti-
nal distress [162].
2.10  What is the Optimal Dose of Caffeine?
One of the basic questions for those interested in caffeine 
supplementation is “What dose of caffeine should I use?” 
Close scrutiny of current evidence highlights we do not 
have a clear answer to this question, as the large majority of 
studies examining the effects of caffeine ingestion on exer-
cise performance use a single dose of caffeine. It, therefore, 
remains unclear if higher doses of caffeine result in greater 
performance-enhancing effects.
In general, studies conducted thus far utilizing differ-
ent doses of caffeine do not necessarily support a linear 
dose–response relationship between caffeine dose and the 
magnitude of its ergogenic effect. Pasman et al. [169] used 
doses of 5, 9, and 13 mg/kg, and reported that all doses were 
equally effective in enhancing cycling performance. Graham 
and Spriet [170] compared the effects of 3, 6, and 9 mg/kg 
on performance in a time to exhaustion test, observing that 
only the two lower doses enhanced performance. Desbrow 
et al. [171] compared the effects of 3 versus 6 mg/kg and 
reported that both doses enhanced aerobic endurance, with 
no between-dose differences.
However, studies utilizing high-intensity, maximal-
exertion exercises performance tests report that, in certain 
instances, higher doses do result in greater improvements 
in performance. For example, Astorino et al. [172] reported 
that 5 mg/kg but not 2 mg/kg of caffeine increased peak 
torque. Pallarés et al. [173] reported that a dose of 9 mg/kg 
was ergogenic for contraction velocity in high-load resist-
ance exercise (90% of 1 RM), while doses of 3 and 6 mg/
kg were not (similar results were observed for 6-s cycling 
peak power output in the same study). Sabol et al. [132] 
found that, compared to placebo, caffeine doses of 2, 4 and 
6 mg/kg were all effective in enhancing lower-body ballistic 
exercise performance; however, only a dose of 6 mg/kg 
enhanced upper-body ballistic exercise. Similarly, Tallis and 
Yavuz [174] reported that 6 mg/kg of caffeine, as compared 
to placebo, enhanced isokinetic force production, whilst a 
lower dose of caffeine (3 mg/kg) did not.
The divergent results for the effects of varying doses of 
caffeine in different exercise tasks might be explained by 
the mechanisms of caffeine. When ingested, caffeine elic-
its many physiological responses in the body, which makes 
it difficult to isolate the mechanism by which it enhances 
performance. However, there is evidence that caffeine’s 
reduction of rating of perceived exertion (RPE) is one of 
the primary explanatory reasons for its ergogenic effects on 
aerobic exercise performance [11]. Caffeine binds to adeno-
sine receptors, subsequently reducing RPE during exercise. 
McLellan and colleagues [105] suggested a threshold plasma 
caffeine concentration of 15–20 μM (generally attained from 
a dose of 3 mg/kg) is required to experience an ergogenic 
effect during aerobic exercise. In this context, it might be 
that a lower dose of caffeine (e.g., 3 mg/kg) is sufficient for 
caffeine to bind to the adenosine receptors, reduce RPE, and 
enhance aerobic performance. Therefore, for this exercise 
type, higher doses (e.g., 4–6 mg/kg) may not necessarily 
produce a larger ergogenic effect. Here, the timing of caf-
feine ingestion needs to be considered. One hour of exercise 
has been reported to alter the responses of adenosine recep-
tors [175], which may explain why, in some cases, low doses 
of caffeine, when administered during exercise, may still 
increase exercise performance [176].
The primary mechanisms by which caffeine increases 
muscular strength, muscular endurance, and power perfor-
mance are potentially related to its ability to augment muscle 
fiber conduction velocity and motor unit recruitment [177]. 
It might be that increasing the dose of caffeine also increases 
these properties in a linear dose–response fashion, poten-
tially explaining the findings of Astorino et al. [172] and Pal-
larés et al. [173]. Indeed, a meta-analysis by Warren and col-
leagues [16] reported a dose–response relationship between 
caffeine dose and muscular endurance, supporting this idea. 
However, many of the studies exploring the effects of caf-
feine on strength, power, and muscular endurance generally 
do not measure caffeine plasma concentrations, making it 
difficult to determine a minimum plasma concentration for 
the ergogenic effect of caffeine in this exercise type. Finally, 
we acknowledge that these ideas are merely hypotheses and 
remain to be explored in future research.
Alternatively, these contrasting findings might be related 
to the statistical power of the studies. Most of the studies 
examining the effects of varying doses of caffeine included 
fewer than 20 participants [19, 144, 169, 171, 178–180], as 
detailed in Table 5. In a study with 101 participants, Guest 
et al. [58] reported that doses of 2 and 4 mg/kg were com-
parably effective for acute increases in 10-km cycling time 
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trial performance. As such, these results are the most robust 
evidence that greater improvements in performance are not 
attained by increasing the dose of caffeine.
Future studies with larger sample sizes are needed to truly 
determine the optimal caffeine dose. Future studies should 
also employ performance tests for which it is well-estab-
lished that caffeine is ergogenic. For instance, Trevino et al. 
[180] compared the effects of 5 and 10 mg/kg of caffeine on 
isometric strength. Their results indicated that neither of the 
doses were effective for acute increases in strength; however, 
they tested the strength of the elbow flexors, and previous 
research has demonstrated that caffeine is not always ergo-
genic for this muscle group [177].
Until more studies using multiple doses of caffeine on 
exercise performance are conducted, current conclusions 
can only be that doses in the range from 2 to 9 mg/kg (when 
administered in anhydrous, powdered form) are required for 
acute performance-enhancing effects. Still, there remains a 
possibility that optimal dosages are administration time- 
[176], task- [173], and individual-dependent [44], especially 
given the interactions of dose and genotype in the Guest and 
colleagues [58] study detailed above. Optimal doses may 
also depend on caffeine source, as there is evidence that very 
low doses of caffeine administered in caffeinated-chewing 
gum (e.g., an absolute dose of 100 mg) are also ergogenic 
[181]. While the question of the optimal caffeine dose for 
acute performance enhancement is a basic one, we are cur-
rently far from being able to answer it, and future studies 
should aim to explore this area further.
2.11  Does Age Modify Caffeine Ergogenicity?
Whilst we might typically focus on the ergogenic effects 
of caffeine in younger participants, caffeine’s performance-
enhancing effects may hold promise as a method of acutely 
enhancing exercise capacity, performance, and activities of 
daily living in older adults. Research has demonstrated that 
caffeine is effective in enhancing exercise performance in 
older adults [124, 182]; however, there is the possibility that 
the magnitude of ergogenic effects varies with age.
Early work by Swift and Tiplady [183] suggested that 
older adults were more sensitive to caffeine in terms of 
psychomotor changes, measured by changes in choice 
reaction time and attentional levels, compared to younger 
subjects. Utilizing an isolated mouse muscle methodol-
ogy, Tallis et al. [184] reported that, whilst caffeine was 
ergogenic across a range of ages, the magnitude of perfor-
mance improvements tended to be reduced in the muscles 
of the oldest (50 weeks) and youngest (3 weeks) mice when 
compared to middle-aged (10- and 30-week-old) mice. To 
our knowledge, these studies represent the only research 
to date directly comparing younger and older subjects in 
terms of caffeine ergogenicity, demonstrating the potential 
importance of further work in older adults, particularly 
given the health benefits of enhanced exercise performance 
in such a population. Additional nuance may need to be 
explored here, given the potential negative effects of caf-
feine ingestion on bone mineral density [185, 186] and 
blood pressure [187, 188], although caffeine and/or cof-
fee consumption does appear to be protective of cognitive 
function with ageing [189], and tends to be associated with 
improved all-cause mortality [190].
3  Conclusion
Whilst caffeine has a clear, well-established performance-
enhancing effect on exercise performance [5–18, 191], there 
are still many practical aspects regarding its use within sport 
and exercise that remain poorly understood. The aspects 
introduced here represent our thoughts on areas that require 
further exploration in order to better inform and enhance 
caffeine use strategies in athletes. They are not exhaustive, 
with other authors having suggested additional aspects. For 
example, Burke [142] explored the interaction of caffeine 
with other ingredients, which is an important consideration 
given that athletes often co-ingest caffeine with other ergo-
genic aids, such as carbohydrates and taurine in the case of 
caffeine-containing energy drinks, both of which are them-
selves capable of exerting ergogenic effects [192, 193]. 
Additionally, a review by Shabir et al. [194] reported poten-
tial expectancy effects of caffeine in 13 out of 17 identified 
studies, suggesting that if an individual believes they have 
consumed caffeine, and believes that caffeine is ergogenic, 
they are likely to experience a performance benefit, even if 
caffeine has not been consumed. Similarly, correct identi-
fication of administration of caffeine or placebo by study 
participants can modify their performance [195]. As a result, 
researchers should attempt to control for caffeine expectancy 
in intervention studies, and also collect data as to the effec-
tiveness of their blinding procedures. Finally, given that 
the majority of studies on the topic of caffeine and exercise 
explore its effects only in laboratory conditions, as noted by 
Burke [98], further research should seek to replicate actual 
practices in sport, similar to those demonstrated in recent 
studies across a variety of sports, including volleyball [196], 
rugby [23, 197], soccer [198, 199], basketball [200], and 
swimming [201].
Accordingly, it is clear that our understanding of some 
of the nuances of caffeine and performance remains 
incomplete. We hope that the aspects identified within 
this review provide some directions for future research, 
allowing athletes to better harness the ergogenic effects 
of caffeine.
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